Tina Joseph
Overview
Explore the profile of Tina Joseph including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
37
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pham H, Gangoo-Dookhan T, Hale G, Perez A, Joseph T
J Pharm Technol
. 2023 Sep;
39(5):207-211.
PMID: 37745726
Transition of care (TOC) refers to the movement of patients between different health care settings due to changes in medical conditions and needs. Pharmacists can play an important role in...
2.
Davis D, Hale G, Moreau C, Joseph T, Perez A, Rosario E
J Pharm Pract
. 2022 Aug;
37(1):27-34.
PMID: 35981874
Medication nonadherence is the leading cause of poor health outcomes and increased risk of hospitalizations. Previous studies have shown that pharmacist interventions can help improve medication adherence and CMS quality...
3.
Joseph T, Gibbs L, Pham K
J Fam Pract
. 2022 Mar;
71(1):E18-E21.
PMID: 35259334
YES. For both normal-weight and obese men with low testosterone levels and hypogonadal symptoms, selective estrogen receptor modulators (SERMs), such as clomiphene citrate (CC) and enclomiphene citrate (EC), appear to...
4.
Moreau C, Joseph T, Hale G, Brice K, Tran Y
Curr Pharm Teach Learn
. 2022 Feb;
14(1):83-87.
PMID: 35125199
Background: Pharmacy graduates should be prepared to provide patient care in a variety of healthcare settings as members of an interprofessional collaborative team. College-based pharmacy call centers can serve as...
5.
Acharya R, Joseph T, Moreau C, Hale G, Perez A, Rosario E
Sr Care Pharm
. 2021 Dec;
36(12):687-692.
PMID: 34861909
To evaluate the difference in the occurrence of chronic obstructive pulmonary disease (COPD) exacerbations six months preconversion compared with six months postconversion from the branded inhaled corticosteroid/long-acting beta 2-agonist inhalers...
6.
Joseph T, Hale G, Moreau C, Kourtakis S, Wolowich W
Sr Care Pharm
. 2021 May;
36(6):311-316.
PMID: 34016228
Objective: To assess the impact of pharmacist-led transitions of care program on 30-day readmission rates in the accountable care organization (ACO) primary care setting. Design: Retrospective cohort study. Setting: Two...
7.
Joseph T, Hale G, Moreau C
Int J Clin Pharm
. 2021 Jan;
43(3):756-758.
PMID: 33439425
Transitions of care has emerged as a point of vulnerability in global health care systems, which can lead to potential avoidable medical errors. In the United States, pharmacist-led transitions of...
8.
Joseph T, Hale G, Moreau C, Rosario E, Logan N, Perez A
J Pharm Pract
. 2020 Dec;
35(3):363-368.
PMID: 33302778
Background: The Centers for Medicare and Medicaid Services (CMS) publishes quality measures to gauge performance in Accountable Care Organizations (ACOs). ACO-27 (Diabetes Mellitus: Hemoglobin A1c Poor Control) and ACO-41 (Diabetes:...
9.
Moreau C, Maravent S, Hale G, Joseph T
J Pharm Pract
. 2020 Dec;
34(1):7-10.
PMID: 33267726
In recent months, the coronavirus pandemic has significantly affected almost every industry in the United States, including health care and higher education. Faculty and students at colleges and schools of...
10.
Hale G, Moreau C, Joseph T, Phyu J, Merly N, Tadros N, et al.
J Pharm Pract
. 2020 Jun;
34(6):888-893.
PMID: 32578473
Background: As health care moves into the era of value-based medicine, both ambulatory and acute settings are being held accountable for the quality of care provided to patients. Previous studies...